Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Tobin Mark Robert Insider Profile
4 Followers
Tobin Mark Robert, Director at Innovation Pharmaceuticals, holds ― shares in Innovation Pharmaceuticals (Ticker: IPIX), holds 12.19K shares in Lightbridge (Ticker: LTBR). Most recently, Tobin Mark Robert ― shares of Innovation Pharmaceuticals on ― for an estimated value of ―.
Tobin Mark Robert has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tobin Mark Robert holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tobin Mark Robert
Tobin Mark Robert's Trading History
Innovation Pharmaceuticals
―
Director
―
―
Lightbridge
Jan 05, 2023
Director
Uninformative Buy
―
$46.57K
List of latest transactions for each holding click on a transaction to see Tobin Mark Robert's performance on stock
You May Also Like
Tobin Mark Robert insider profile FAQ
What is the percentage of profitable transactions made by Tobin Mark Robert?
The percentage of profitable transactions made by Tobin Mark Robert is ―.
What is the average return per transaction made by Tobin Mark Robert?
The average return per transaction made by Tobin Mark Robert is ―.
What stocks does Tobin Mark Robert hold?
Tobin Mark Robert holds: IPIX, LTBR stocks.
What was Tobin Mark Robert’s latest transaction?
Tobin Mark Robert latest transaction was an Uninformative Buy of ―.
What was Tobin Mark Robert's most profitable transaction?
Tobin Mark Robert’s most profitable transaction was an Informative Sell of LTBR stock on March 29, 2022. The return on the trade was 55.20%.
What is Tobin Mark Robert's role in Innovation Pharmaceuticals?
Tobin Mark Robert's role in Innovation Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.